Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) PT at $348.33

Shares of Astera Labs, Inc. (NASDAQ:ALABGet Free Report) have received a consensus rating of “Moderate Buy” from the twenty-one research firms that are currently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $348.3333.

A number of research analysts have recently commented on the company. Morgan Stanley increased their price target on Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Bank of America increased their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Evercore restated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th.

Get Our Latest Analysis on Astera Labs

Astera Labs Price Performance

ALAB stock opened at $291.22 on Monday. The company has a 50 day simple moving average of $316.60 and a 200 day simple moving average of $260.17. The stock has a market cap of $50.52 billion, a price-to-earnings ratio of 144.17 and a beta of 3.77. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts anticipate that Astera Labs will post 2.7 EPS for the current fiscal year.

Insider Activity at Astera Labs

In related news, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 592,244 shares of company stock valued at $209,729,973 in the last quarter. Insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Capstone Financial Advisors Inc. bought a new stake in shares of Astera Labs in the 2nd quarter valued at $274,000. Sequoia Financial Advisors LLC boosted its position in Astera Labs by 19.0% during the second quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock valued at $1,776,000 after acquiring an additional 588 shares during the last quarter. Archford Capital Strategies LLC acquired a new stake in Astera Labs during the 2nd quarter worth about $506,000. Integrated Wealth Concepts LLC grew its holdings in Astera Labs by 0.7% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock worth $3,384,000 after acquiring an additional 52 shares during the period. Finally, IFP Advisors Inc raised its position in shares of Astera Labs by 9.2% in the 2nd quarter. IFP Advisors Inc now owns 4,241 shares of the company’s stock worth $2,048,000 after acquiring an additional 356 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

See Also

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.